For patients at high cardiovascular risk with obesity, semaglutide is associated with reduced burden of total hospital admissions.

For patients with hypertension, initiating treatment with an ARB is associated with the best long-term class persistence.

Accelerated linear growth and weight gain from birth to 4 years of age are associated with earlier pubertal onset, particularly in girls.

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Among individuals with T2D, young-onset hypertension (defined as onset before 45 years of age) is associated with a greater magnitude of risk for most cardiovascular outcomes, including hemorrhagic ...

Higher consumption of proinflammatory or hyperinsulinemic diets is associated with an increased risk for T2D and unfavorable cardiometabolic profiles among women with a history of gestational diabetes ...

Five diabetes subgroups possess specific comorbidity risk profiles, with SIRD and SIDD generally exhibiting the highest risks for kidney disease, myocardial infarction, and total mortality compared ...

Inhaled Technosphere insulin (TI) did not meet the prespecified noninferiority margin for HbA1c compared with subcutaneous rapid-acting analog (RAA) insulin among youth with diabetes over 26 weeks.

Greater adherence to the Planetary Health Diet is associated with better weight outcomes and a lower risk for myocardial infarction among women with a history of gestational diabetes. Greater ...

Among patients with diabetes who require in-center hemodialysis, the use of GLP-1 receptor agonists is associated with a lower risk of developing Alzheimer disease and related dementias compared with ...

Credit: Getty Images Unlike other states that prohibit gender-affirming care for minors, Texas is unique in that the Attorney General has filed civil lawsuits against physicians. On June 2, 2023, ...

Women with prepregnancy obesity are more likely to have children with neurodevelopmental disabilities, specifically showing greater risks for epilepsy and intellectual disability. Women with ...